Idéal Investisseur
Français English
CAC 40 : Market open
8 170,54 pts
-0.40%


Last updated : 10/06/2026 - 14h19
🏠 Home   ➤    Stock news

Eurofins Scientific Stock Rises 2.65%, Approaching a Key Technical Threshold


Eurofins Scientific Stock Rises 2.65%, Approaching a Key Technical Threshold

Eurofins Scientific's stock closed the session on Thursday, October 16, with a rise of 2.65%, reaching €63.48, up from €61.84 the previous day. This increase is part of a positive short and medium-term momentum, with a gain of 1.89% over the past week and 5.31% over the last three months. The traded volumes remained moderate, representing 0.18% of the capital, indicating sustained activity without signaling a massive influx of orders. Meanwhile, the CAC 40 also recorded a significant rise of 1.38%, but Eurofins slightly outperformed the Parisian index in this session. Over the past year, the stock has shown a performance of 14.83%, significantly higher than the CAC 40's 8.86% over the same period. This progression places the stock in a favorable long-term trend, although there have been some consolidation phases in recent weeks. The closing of the day positions Eurofins just below a technical resistance threshold at €64.00, a level that also coincides with its 50-day moving average. This double barrier is a point of attention for the upcoming sessions, especially since the consensus of analysts, published recently, places the median target price at €63.84, barely above the current price.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

From a technical chart perspective, several elements help to better understand the situation. The MACD, a momentum indicator, shows a slightly positive histogram at 0.04, suggesting a beginning of recovery after a period of weakness. However, this improvement remains fragile, with the signal line still above the MACD line. Concurrently, the stock is trading above the upper Bollinger band, set at €63.41, which may indicate a breakout on the upside after a period of volatility contraction. Such a configuration often translates to a temporary acceleration in prices, but requires confirmation to sustain a long-term trend. The Relative Strength Index (RSI) is at 57, in a neutral zone, with no overbought or oversold signals. This positioning allows room for movement both upwards and downwards. Additionally, the monthly volatility of the stock remains contained at 4%, and its beta of 0.14 indicates a very low sensitivity to movements in the CAC 40. This relative stability may attract investors looking for stocks less exposed to market fluctuations. Lastly, the stock maintains a strong position well above its 200-day moving average, set at €56.90, reflecting a positive long-term trend for several months. The technical support at €60.80 remains distant, providing a safety margin in case of a short-term reversal.



Sector Santé · Vaccins et laboratoires de recherche Services médicaux


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Contexte

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 1789M€
Guidance from the release
  • Eurofins a rencontré des vents contraires importants et temporaires.
  • Malgré une croissance organique modérée, la rentabilité et les marges progressent.
Risks mentioned
  • Baisse de la demande en raison de conditions climatiques défavorables en Amérique du Nord.
  • Rationalisation des contrats dans les diagnostics cliniques en Espagne et en Italie.
Opportunities identified
  • Lancement de nouveaux contrats renforçant notre portefeuille BioPharma.
  • Initiatives de digitalisation et amélioration du réseau de laboratoires.

Les informations présentées dans cet article sont fournies à titre purement indicatif et ne constituent en aucun cas une recommandation d'investissement, une incitation à acheter ou vendre un actif financier, ni un conseil en placement. Le lecteur est invité à réaliser ses propres recherches avant toute décision.

Les investissements en bourse comportent des risques, notamment de perte en capital. La performance passée d'un actif ou d'un marché ne présage en rien de ses performances futures. Toute décision d'investissement doit être prise en tenant compte de votre situation financière personnelle, de vos objectifs et de votre tolérance au risque.

Annonce
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours